Prevalence of use and acute toxicity associated with the use of NBOMe drugs

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Clinical toxicology

• Publication date

  2015-02-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/15563650.2015.1004179PMID 25658166
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 2014 Annual Meeting of the North American Congress of Clinical Toxicology (NACCT)

  2014cited by this paper
• Pathological Findings in 2 Cases of Fatal 25I-NBOMe Toxicity

  2014cited by this paper
• Pediatric ergot alkaloid exposures reported to the California Poison Control System: 1997–2008

  2014cited by this paper
• Lebensgefährliche Intoxikation mit der neuen psychoaktiven Substanz 25C-NBOMe

  2014cited by this paper
• Two cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe

  2014cited by this paper
• Postmortem detection of 25I-NBOMe [2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine] in fluids and tissues determined by high performance liquid chromatography with tandem mass spectrometry from a traumatic death.

  2014cited by this paper
• Determination of 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (25B-NBOMe) in serum and urine by high performance liquid chromatography with tandem mass spectrometry in a case of severe intoxication.

  2014cited by this paper
• The NBOMe hallucinogenic drug series: Patterns of use, characteristics of users and self-reported effects in a large international sample

  2014cited by this paper
• The electric Kool-Aid NBOMe test: LC-TOF/MS confirmed 2C-C-NBOMe (25C) intoxication at Burning Man.

  2014cited by this paper
• NBOMe Designer Drug Exposures Reported to Texas Poison Centers

  2014cited by this paper
• [Near fatal intoxication with the novel psychoactive substance 25C-NBOMe].

  2014cited by this paper
• Two new synthetic cannabinoids, AM-2201 benzimidazole analog (FUBIMINA) and (4-methylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)methanone (MEPIRAPIM), and three phenethylamine derivatives, 25H-NBOMe 3,4,5-trimethoxybenzyl analog, 25B-NBOMe, and 2C-N-NBOMe, identified in illegal products

  2013cited by this paper
• A case of 25I-NBOMe (25-I) intoxication: a new potent 5-HT2A agonist designer drug

  2013cited by this paper
• Severe clinical toxicity associated with analytically confirmed recreational use of 25I–NBOMe: case series

  2013cited by this paper
• The vasoactive properties of the novel psychoactive substance methoxetamine

  2013cited by this paper
• 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): Clinical Case with Unique Confirmatory Testing

  2013cited by this paper
• Do Novel Psychoactive Substances Displace Established Club Drugs, Supplement Them or Act as Drugs of Initiation? The relationship between Mephedrone, Ecstasy and Cocaine

  2013cited by this paper
• NBOMe — a very different kettle of fish …

  2013cited by this paper
• High-performance liquid chromatography tandem mass spectrometry method for the determination of 2CC-NBOMe and 25I-NBOMe in human serum.

  2013cited by this paper
• Erratum to: Two new synthetic cannabinoids, AM-2201 benzimidazole analog (FUBIMINA) and (4-methylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)methanone (MEPIRAPIM), and three phenethylamine derivatives, 25H-NBOMe 3,4,5-trimethoxybenzyl analog, 25B-NBOMe, and 2C-N-NBOMe, identified in illegal products

  2013cited by this paper
• Limited use of novel psychoactive substances in South London nightclubs.

  2012cited by this paper
• ‘Our favourite drug’: prevalence of use and preference for mephedrone in the London night-time economy 1 year after control

  2012cited by this paper
• Abstracts of the 2011 International Congress of the European Association of Poisons Centres and Clinical Toxicologists, 24–27 May 2011, Dubrovnik, Croatia

  2011cited by this paper
• Minimal structures , generalized topologies , and ascending systems should not be studied without generalized uniformities

  2007cited by this paper
• The European Monitoring Centre for Drugs and Drug Addiction

  1998cited by this paper

• Triggers of Highly Lethal Seizures Induced by Novel Stimulants: A Systematic Review Focused on Synthetic Cathinones and Phenethylamines.

  2026cites this paper
• Acute and long-term psychiatric consequences of synthetic cannabinoids and related novel psychoactive substances: A systematic review.

  2026cites this paper
• The Role of Mitochondrial Dysfunction and Calcium Dysregulation in 2C-I and 25I-NBOMe-Induced Neurotoxicity.

  2025cites this paper
• Novel Psychoactive Substances and Psychosis: A Comprehensive Systematic Review of Epidemiology, Clinical Features, Neurobiology, and Treatment.

  2025cites this paper
• Electrochemical Simulation of 25B-NBOMe Phase I Metabolism and Metabolite Profiling by HPLC-QTOF-MS

  2025cites this paper
• The novel psychoactive substance 25E-NBOMe induces reward-related behaviors via dopamine D1 receptor signaling in male rodents

  2024cites this paper
• Effects and Toxicity of Hallucinogenic New Psychoactive Substances From the Perspectives of e-Psychonauts

  2024cites this paper
• Metabolic characterization of 25X-NBOH and 25X-NBOMe phenethylamines based on UHPLC-Q-Exactive Orbitrap MS in human liver microsomes.

  2024cites this paper
• Exposure to the Psychedelic Substance 25H-NBOMe Disrupts Maternal Care in Lactating Rats and Subsequently Impairs the Social Play Behavior of the Offspring.

  2024cites this paper
• Neurotoxic effects of hallucinogenic drugs 25H-NBOMe and 25H-NBOH in organotypic hippocampal cultures

  2023cites this paper
• Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential

  2023cites this paper
• Acute, chronic, and post-mortem toxicity: a review focused on three different classes of new psychoactive substances

  2023cites this paper
• New Psychoactive Substances: Major Groups, Laboratory Testing Challenges, Public Health Concerns, and Community-Based Solutions

  2023cites this paper
• Identification of 5-HT2A Receptor Signaling Pathways Responsible for Psychedelic Potential

  2023cites this paper
• 25X-NBOMe compounds – chemistry, pharmacology and toxicology. A comprehensive review

  2023cites this paper
• Rewarding and Reinforcing Effects of 25H-NBOMe in Rodents

  2022cites this paper
• Pharmacology and toxicology of N-Benzyl-phenylethylamines (25X-NBOMe) hallucinogens

  2022cites this paper
• Knowledge and Use of Novel Psychoactive Substances in an Italian Sample with Substance Use Disorders

  2022cites this paper
• Fatal Intoxications from a Combination of 4-Fluoroamphetamine and 25C-NBOMe.

  2022cites this paper
• Pharmacokinetics, systemic toxicity, thermoregulation and acute behavioural effects of 25CN‐NBOMe

  2022cites this paper
• A simplified strategy to assess the cytotoxicity of new psychoactive substances in HepG2 cells using a high content screening assay - Exemplified for nine compounds.

  2022cites this paper
• Acute behavioral and Neurochemical Effects of Novel N-Benzyl-2-Phenylethylamine Derivatives in Adult Zebrafish.

  2022cites this paper
• Effect of -NBOMe Compounds on Sensorimotor, Motor, and Prepulse Inhibition Responses in Mice in Comparison With the 2C Analogs and Lysergic Acid Diethylamide: From Preclinical Evidence to Forensic Implication in Driving Under the Influence of Drugs

  2022cites this paper
• Behavioral and neurochemical effects of novel N-Benzyl-2-phenylethylamine derivatives in adult zebrafish

  2022cites this paper
• The new psychoactive substances 25H-NBOMe and 25H-NBOH induce abnormal development in the zebrafish embryo and interact in the DNA major groove

  2021cites this paper
• New Psychoactive Substances Constant State of Flux: NBOMe Brazilian Case

  2021cites this paper
• Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics.

  2021cites this paper
• Recreational drugs 25I-NBOH and 25I-NBOMe bind to both Sudlow's sites I and II of human serum albumin (HSA): biophysical and molecular modeling studies

  2021cites this paper
• New psychoactive substances: a review and updates

  2020cites this paper
• NBOMes–Highly Potent and Toxic Alternatives of LSD

  2020cites this paper
• 25I-NBOME (2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine)-A HARMFUL HALLUCINOGEN REVIEW.

  2020cites this paper
• Sex and Gender Differences in the Effects of Novel Psychoactive Substances

  2020cites this paper
• Development and validation of a colour spot test method for the presumptive detection of 25-NBOMe compounds.

  2020cites this paper
• 25I-NBOMe, a phenethylamine derivative, induces adverse cardiovascular effects in rodents: possible involvement of p21 (CDC42/RAC)-activated kinase 1

  2020cites this paper
• Synthesis, determination of analytical characteristics and differentiation of positional isomers in the series of N-(2-methoxybenzyl)-2-(dimethoxyphenyl)ethanamine by means of chromatography-mass spectrometry.

  2020cites this paper
• Designer drugs: a medicinal chemistry perspective (II)

  2020cites this paper
• Designer drugs: mechanism of action and adverse effects

  2020cites this paper
• Management of pharmaceutical and recreational drug poisoning

  2020cites this paper
• Substance-Use Disorders and Violence

  2019cites this paper
• Development and validation of a LC-ESI-MS/MS method for simultaneous whole blood analysis of 51 new psychoactive substances

  2019cites this paper
• A novel designer drug, 25N-NBOMe, exhibits abuse potential via the dopaminergic system in rodents.

  2019cites this paper
• NBOMe compounds: An overview about analytical methodologies aiming their determination in biological matrices

  2019cites this paper
• Abuse potential of 2‐(4‐iodo‐2, 5‐dimethoxyphenyl)‐N‐(2‐methoxybenzyl)ethanamine (25I‐NBOMe); in vivo and ex vivo approaches

  2019cites this paper
• On‐site identification of psychoactive drugs by portable Raman spectroscopy during drug‐checking service in electronic music events

  2019cites this paper
• 25C-NBOMe, a Novel Designer Psychedelic, Induces Neurotoxicity 50 Times More Potent Than Methamphetamine In Vitro

  2019cites this paper
• Fourier transform mass spectrometry applied to Forensic Chemistry

  2019cites this paper
• Patterns of Acute Toxicity Associated with New Psychoactive Substances.

  2018cites this paper
• 9-year review of new psychoactive substance use in Hong Kong: A clinical laboratory perspective

  2018cites this paper
• Neurochemical pharmacology of psychoactive substituted N‐benzylphenethylamines: High potency agonists at 5‐HT2A receptors

  2018cites this paper
• Metabolic profile determination of 25N-NBOMe in human liver microsomes by liquid chromatography-quadrupole time-of-flight mass spectrometry

  2018cites this paper
• Neurotoxicity screening of new psychoactive substances (NPS): Effects on neuronal activity in rat cortical cultures using microelectrode arrays (MEA)

  2018cites this paper
• Consommation de substances psychoactives au cours des Ferias du Sud-Ouest : quelles substances en cause et quels tableaux cliniques pour les patients admis dans les postes médicaux avancés ? (étude prospective FERIATOX°)

  2017cites this paper
• Novel psychoactive substances: types, mechanisms of action, and effects

  2017cites this paper
• MDMB-CHMICA: Availability, Patterns of Use, and Toxicity Associated With This Novel Psychoactive Substance

  2017cites this paper
• Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents

  2017cites this paper
• Characterization of the hepatic cytochrome P450 enzymes involved in the metabolism of 25I-NBOMe and 25I-NBOH.

  2017cites this paper
• An approach to the new psychoactive drugs phenomenon

  2017cites this paper
• Drug Recognition Evaluation and Chemical Confirmation of a 25C‐NBOMe‐Impaired Driver

  2017cites this paper
• Identification of novel psychoactive substances 25B-NBOMe and 4-CMC in biological material using HPLC-Q-TOF-MS and their quantification in blood using UPLC-MS/MS in case of severe intoxications.

  2017cites this paper
• Seizures, Systemic Inflammatory Response, and Rhabdomyolysis Associated With Laboratory-Confirmed 2C-I and 25-I Exposure

  2017cites this paper
• Novel psychoactive substances: a practical approach to dealing with toxicity from legal highs

  2017cites this paper
• The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations.

  2017cites this paper
• Emerging Drugs of Abuse: Synthetic Cannabinoids, Phenylethylamines (2C Drugs), and Synthetic Cathinones

  2017cites this paper
• NBOMe Compounds: Systematic Review and Data Crunching of the Surface Web

  2017influential citation
• Retrospective identification of 25I-NBOMe metabolites in an intoxication case

  2017cites this paper
• Synthesis and identification of metabolite biomarkers of 25C-NBOMe and 25I-NBOMe

  2017cites this paper
• LSD instead of 25I-NBOMe: The revival of LSD? A case report

  2017cites this paper
• Rapid Screening Method for New Psychoactive Substances of Forensic Interest: Electrochemistry and Analytical Determination of Phenethylamines Derivatives (NBOMe) via Cyclic and Differential Pulse Voltammetry.

  2017cites this paper
• Pharmacology and Toxicology of N-Benzylphenethylamine ("NBOMe") Hallucinogens.

  2017cites this paper
• Acute Toxicity Related to 25G-NBOMe Use: An Internet High.

  2017cites this paper
• NPS: Medical Consequences Associated with Their Intake.

  2016cites this paper
• NBOMe: perfil de apreensões da Polícia Federal no Brasil

  2016cites this paper
• PENGARUH EKSTRAK DAUN DEWA (GYNURA DIVARICATA) TERHADAP KADAR UREUM DAN KREATININ : STUDI EKSPERIMENTAL PADA TIKUS MODEL KANKER PAYUDARA

  2016cites this paper
• Novel psychoactive substances: the pharmacology of stimulants and hallucinogens

  2016cites this paper
• Recommendations for specimen collection for NBOMe analysis in clinical toxicology

  2016cites this paper
• New psychoactive substance use among regular psychostimulant users in Australia, 2010-2015.

  2016cites this paper
• What products are considered psychoactive under New Zealand's legal market for new psychoactive substances (NPS, 'legal highs')? Implications for law enforcement and penalties.

  2016cites this paper
• Neurochemical binding profiles of novel indole and benzofuran MDMA analogues

  2016cites this paper
• Healthcare professionals are less confident in managing acute toxicity related to the use of new psychoactive substances (NPS) compared with classical recreational drugs.

  2016cites this paper
• New psychoactive substances: an overview on recent publications on their toxicodynamics and toxicokinetics

  2016cites this paper
• Case series: toxicity from 25B-NBOMe – a cluster of N-bomb cases

  2016cites this paper
• Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants

  2016cites this paper
• Evaluating and Expanding Knowledge and Awareness of Health Professionals on the Consumption and Adverse Consequences of Novel Psychoactive Substances (NPS) Through Innovative Information Technologic Tools

  2015cites this paper
• Next generation of novel psychoactive substances on the horizon - A complex problem to face.

  2015cites this paper
• Nuevas Drogas Psicoactivas New Psychoactive Drugs

  2015cites this paper
• New Psychoactive Drugs Nuevas Drogas Psicoactivas

  2015cites this paper
• New Psychoactive Drugs.

  2015cites this paper
• Thrombocytopenia with quetiapine: two case reports, one with positive rechallenge.

  2015cites this paper
• NBOMe and 2C substitute phenylethylamine exposures reported to the National Poison Data System

  2015influential citation
• NBOMe: a new dangerous drug similar to LSD.

  2015cites this paper
• Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs).

  2015influential citation
• Beware of blotting paper hallucinogens: severe toxicity with NBOMes

  2015cites this paper